http://www.renalandurologynews.com Latest articles from Renal and Urology News Secondary Hyperparathyroidism RUN Secondary Hyperparathyroidism News and review articles on secondary hyperparathyroidism. Secondary Hyperparathyroidism custserv@haymarketmedia.com no Emerging data suggest that thyroid hormone deficiency may be associated with 
greater cardiovascular morbidity and mortality in this population. http://www.renalandurologynews.com/thyroid-functional-disease-in-dialysis-patients/article/283484/ Fri, 01 Mar 2013 05:00:00 GMT Emerging data suggest that thyroid hormone deficiency may be associated with 
greater cardiovascular morbidity and mortality in this population. RUN Researchers find a 'nominally significant' decrease in the risk of a composite outcome of death and nonfatal major cardiovascular events. http://www.renalandurologynews.com/cinacalcets-cardiovascular-benefits-modest-in-dialysis-patients/article/274046/ Thu, 27 Dec 2012 12:53:22 GMT Researchers find a 'nominally significant' decrease in the risk of a composite outcome of death and nonfatal major cardiovascular events. RUN Phosphate level is a stronger predictor for increased mortality among hemodialysis (HD) patients than calcium and parathyroid hormone (PTH) levels. http://www.renalandurologynews.com/give-priority-to-phosphate-control-researchers-conclude/article/266762/ Fri, 02 Nov 2012 21:30:00 GMT Phosphate level is a stronger predictor for increased mortality among hemodialysis (HD) patients than calcium and parathyroid hormone (PTH) levels. RUN Hyperparathyroidism develops prior to significant hyperphosphatemia in patients with chronic kidney disease (CKD) but not on dialysis. http://www.renalandurologynews.com/higher-phosphate-pth-predict-worse-outcomes/article/266178/ Fri, 02 Nov 2012 00:15:00 GMT Hyperparathyroidism develops prior to significant hyperphosphatemia in patients with chronic kidney disease (CKD) but not on dialysis. RUN Greater body mass index and waist circumference increases risk of secondary hyperparathyroidism, hyperphosphatemia, and hypertension. http://www.renalandurologynews.com/ckd-complications-linked-to-bmi-waist-size/article/261815/ Wed, 03 Oct 2012 11:30:00 GMT Greater body mass index and waist circumference increases risk of secondary hyperparathyroidism, hyperphosphatemia, and hypertension. RUN NATIONAL HARBOR, Md.—Low and high levels of parathyroid hormone (PTH) are associated with hypercalcemia, according to a study of 106,760 hemodialysis patients presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest. http://www.renalandurologynews.com/high-low-pth-raises-hypercalcemia-risk/article/240981/ Sun, 13 May 2012 21:00:00 GMT NATIONAL HARBOR, Md.—Low and high levels of parathyroid hormone (PTH) are associated with hypercalcemia, according to a study of 106,760 hemodialysis patients presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest. RUN NATIONAL HARBOR, Md.—An investigational treatment safely and effectively lowers elevated plasma intact parathyroid hormone (iPTH) levels in patients with stage 3 or 4 chronic kidney disease and vitamin D deficiency, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings. http://www.renalandurologynews.com/novel-formulation-corrects-vitamin-d-lowers-ipth/article/240980/ Sun, 13 May 2012 21:00:00 GMT NATIONAL HARBOR, Md.—An investigational treatment safely and effectively lowers elevated plasma intact parathyroid hormone (iPTH) levels in patients with stage 3 or 4 chronic kidney disease and vitamin D deficiency, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings. RUN NATIONAL HARBOR, Md.—Vitamin D deficiency is strongly associated with secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), according to data presented at the National Kidney Foundation (NKF) 2012 Spring Clinical Meetings. http://www.renalandurologynews.com/shpt-linked-to-vitamin-d-deficiency-in-ckd-patients/article/240922/ Sat, 12 May 2012 17:00:00 GMT NATIONAL HARBOR, Md.—Vitamin D deficiency is strongly associated with secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), according to data presented at the National Kidney Foundation (NKF) 2012 Spring Clinical Meetings. RUN NATIONAL HARBOR, Md.—Laboratories can differ in their measurements of intact parathyroid hormone (iPTH) levels, resulting in varying treatment approaches for hemodialysis (HD) patients depending on the iPTH assay used, researchers reported at the National Kidney Foundation Spring Clinical Meetings. http://www.renalandurologynews.com/labs-may-vary-in-ipth-measurements/article/240921/ Sat, 12 May 2012 16:00:00 GMT NATIONAL HARBOR, Md.—Laboratories can differ in their measurements of intact parathyroid hormone (iPTH) levels, resulting in varying treatment approaches for hemodialysis (HD) patients depending on the iPTH assay used, researchers reported at the National Kidney Foundation Spring Clinical Meetings. RUN NATIONAL HARBOR, Md.—Levels of 25-hydroxyvitamin D (25D) higher than 20 ng/mL would be required to normalize intact parathyroid hormone (iPTH) in patients with stages 3 and 4 chronic kidney disease (CKD) with vitamin D insufficiency and secondary hyperparathyroidism, researchers concluded in a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings. http://www.renalandurologynews.com/ckd-patients-may-need-higher-25d-levels/article/240706/ Fri, 11 May 2012 18:00:00 GMT NATIONAL HARBOR, Md.—Levels of 25-hydroxyvitamin D (25D) higher than 20 ng/mL would be required to normalize intact parathyroid hormone (iPTH) in patients with stages 3 and 4 chronic kidney disease (CKD) with vitamin D insufficiency and secondary hyperparathyroidism, researchers concluded in a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings. RUN NATIONAL HARBOR, Md.—Oral calcitriol is as effective as vitamin D analogues for treating secondary hyperparathyroidism (SHPT) in hemodialysis patients but is more cost effective, according to a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings. http://www.renalandurologynews.com/calcitriol-as-effective-as-vitamin-d-analogues-but-cheaper/article/240704/ Fri, 11 May 2012 17:00:00 GMT NATIONAL HARBOR, Md.—Oral calcitriol is as effective as vitamin D analogues for treating secondary hyperparathyroidism (SHPT) in hemodialysis patients but is more cost effective, according to a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings. RUN Changes in calcium, phosphorus, and 25-hydroxyvitamin-D explain only part of this racial difference http://www.renalandurologynews.com/pth-rise-in-ckd-greater-in-blacks/article/238246/ Thu, 26 Apr 2012 12:00:00 GMT Changes in calcium, phosphorus, and 25-hydroxyvitamin-D explain only part of this racial difference RUN The drug was more likely than cinacalcet to achieve a 50 percent or greater decrease in iPTH from baseline. http://www.renalandurologynews.com/paricalcitol-superior-for-lowering-ipth/article/207728/ Mon, 18 Jul 2011 13:29:41 GMT The drug was more likely than cinacalcet to achieve a 50 percent or greater decrease in iPTH from baseline. RUN LAS VEGAS—A novel multivitamin antioxidant nutraceutical may be useful in the treatment of secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients, according to data reported at the National Kidney Foundation's Spring Clinical Meetings. http://www.renalandurologynews.com/antioxidant-nutraceutical-may-help-treat-secondary-hyperparathyroidism/article/201755/ Sat, 30 Apr 2011 12:00:00 GMT LAS VEGAS—A novel multivitamin antioxidant nutraceutical may be useful in the treatment of secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients, according to data reported at the National Kidney Foundation's Spring Clinical Meetings. RUN LAS VEGAS—Statin use by non-diabetic patients with end-stage renal disease may decrease paricalcitol use, researcher reported at the National Kidney Foundation's Spring Clinical Meetings. http://www.renalandurologynews.com/paricalcitol-use-lower-among-non-diabetics-on-statins/article/201697/ Fri, 29 Apr 2011 15:30:00 GMT LAS VEGAS—Statin use by non-diabetic patients with end-stage renal disease may decrease paricalcitol use, researcher reported at the National Kidney Foundation's Spring Clinical Meetings. RUN LAS VEGAS—Inpatient cost savings may offset the costs of patient adherence to cinacalcet therapy, according to study findings presented at the National Kidney Foundation's Spring Clinical Meetings. http://www.renalandurologynews.com/inpatient-savings-may-offset-cinacalcet-costs/article/201695/ Fri, 29 Apr 2011 12:00:00 GMT LAS VEGAS—Inpatient cost savings may offset the costs of patient adherence to cinacalcet therapy, according to study findings presented at the National Kidney Foundation's Spring Clinical Meetings. RUN Percutaneous ethanol injection therapy (PEIT) is a useful and safe treatment alternative for patients with persistent post-transplant secondary hyperparathyroidism, researchers in Argentina report. http://www.renalandurologynews.com/ethanol-may-ease-secondary-hyperparathyroidism-post-tx/article/99089/ Thu, 01 Nov 2007 04:00:00 GMT Percutaneous ethanol injection therapy (PEIT) is a useful and safe treatment alternative for patients with persistent post-transplant secondary hyperparathyroidism, researchers in Argentina report. RUN